Small (

OBJECTIVE The purpose of this study was to evaluate whether mangafodipir trisodium (MnDPDP)-enhanced MRI improves the detection and characterization of small (<or= 2 cm) hepatic lesions in patients with colorectal carcinoma, compared with helical CT. SUBJECTS AND METHODS. Sixty-nine patients who had or were suspected of having focal liver lesions underwent helical CT and MnDPDP-enhanced MRI and constituted the study population. Two experienced radiologists independently reviewed CT and MR images for the number of hepatic lesions seen and whether the lesion appeared to be benign or metastatic; their interpretations were correlated with the reference diagnoses, including histopathologic diagnoses in 35 patients. The lesions were categorized as small (<or= 2.0 cm in diameter) or large (> 2.0 cm). The differences between MnDPDP-enhanced MRI and helical CT with regard to the detection rates for hepatic lesions and metastases and with regard to the false-positive rates for hepatic metastases were analyzed using the McNemar test. The performances of MnDPDP-enhanced MRI and helical CT in indicating metastases of focal liver lesions were analyzed using receiver operating characteristic curves. RESULTS No statistically significant differences were seen between MnDPDP-enhanced MRI and helical CT in the detection of all hepatic lesions (p = 0.383) and small lesions (p = 0.210). However, concerning the differentiation between benign and metastatic lesions, MnDPDP-enhanced MRI was superior to helical CT both for all hepatic lesions (p = 0.023) and for small lesions (p = 0.015), and remained better when the analyses were restricted to patients with histopathologic confirmation (p = 0.023 for both). MnDPDP-enhanced MRI changed the diagnosis of hepatic metastasis in nine (13.0%) of 69 patients. Of 12 metastases that were found on MnDPDP-enhanced MRI and missed on helical CT, 11 lesions (91.7%) were small. MnDPDP-enhanced MRI showed a significantly greater detection rate than helical CT for small hepatic metastases (p = 0.022). MnDPDP-enhanced MRI was better when the analyses were restricted to patients with histopathologic confirmation (p = 0.043). CONCLUSION Although MnDPDP-enhanced MRI is equal to helical CT in detection of both all hepatic lesions and small lesions in patients with colorectal carcinoma, it is superior to CT in characterization of the lesions.

[1]  M. Haider,et al.  Multi-detector row helical CT in preoperative assessment of small (< or = 1.5 cm) liver metastases: is thinner collimation better? , 2002, Radiology.

[2]  T. Ichikawa,et al.  Ferumoxides-enhanced double-echo T2-weighted MR imaging in differentiating metastases from nonsolid benign lesions of the liver. , 2002, Radiology.

[3]  J. Bloem,et al.  Hepatic metastases in patients with colorectal cancer: relationship between size of metastases, standard of reference, and detection rates. , 2002, Radiology.

[4]  Jan Grimm,et al.  Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT. , 2002, Radiology.

[5]  M. Choti,et al.  Liver lesions: manganese-enhanced MR and dual-phase helical CT for preoperative detection and characterization comparison with receiver operating characteristic analysis. , 2002, Radiology.

[6]  R. Semelka,et al.  Focal liver lesions: Comparison of dual‐phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement , 2001, Journal of magnetic resonance imaging : JMRI.

[7]  D. Bluemke,et al.  MR imaging in the evaluation of hepatic metastases. , 2000, Magnetic resonance imaging clinics of North America.

[8]  C. Marx,et al.  Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. , 2000, Radiology.

[9]  P. Robinson,et al.  Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. , 1999, Radiology.

[10]  S. Saini,et al.  Liver-specific MR imaging contrast agents. , 1998, Radiologic clinics of North America.

[11]  N. Heaton,et al.  MnDPDP-enhanced MR imaging of the liver , 1997, Acta radiologica.

[12]  E. Rummeny,et al.  MnDPDP for MR imaging of the liver , 1997, Acta radiologica.

[13]  S. McGill,et al.  MnDPDP for MR imaging of the liver , 1997, Acta radiologica.

[14]  M Oudkerk,et al.  Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging. , 1997, Radiology.

[15]  M S van Leeuwen,et al.  Focal liver lesions: characterization with triphasic spiral CT. , 1996, Radiology.

[16]  R. Baron,et al.  Helical biphasic contrast-enhanced CT of the liver: technique, indications, interpretation, and pitfalls. , 1996, Radiology.

[17]  B. V. Van Beers,et al.  Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. , 1996, Radiology.

[18]  S E Seltzer,et al.  Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. , 1995, Radiology.

[19]  B. Marincek,et al.  Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. , 1995, Radiology.

[20]  R. Semelka,et al.  Solitary hepatic metastasis: Comparison of dynamic contrast‐enhanced CT and MR imaging with fat‐suppressed T2‐weighted, Breath‐hold T1‐weighted FLASH, and dynamic gadolinium‐enhanced FLASH sequences , 1994, Journal of magnetic resonance imaging : JMRI.

[21]  R. Jeffrey,et al.  Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T. , 1993, Radiology.

[22]  A L Baert,et al.  Experimental liver cancers: Mn-DPDP-enhanced rims in MR-microangiographic-histologic correlation study. , 1993, Radiology.

[23]  B. Greenway,et al.  Hepatic metastases from colorectal cancer: Resection or not , 1988, The British journal of surgery.

[24]  J. Hanley,et al.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.

[25]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[26]  J. Figueras,et al.  Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT. , 2001, Radiology.

[27]  L. Schwartz,et al.  Prevalence and importance of small hepatic lesions found at CT in patients with cancer. , 1999, Radiology.

[28]  T. Vogl,et al.  Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients. , 1992, Radiology.